ScandiDos ABOSTO:SDOS +0.60%47 EBITDA Margin % is 5.38% as of Apr. 2026. GuruFocus rates OSTO:SDOS with a GF Score™ of 47/100 and a GF Value™ of kr1.15 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, ScandiDos AB ranks worse than 61.89% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. ScandiDos AB's EBITDA for the
three
months ended in Apr. 2026 was kr0.76 Mil. ScandiDos AB's Revenue for the
three
months ended in Apr. 2026 was kr14.15 Mil. Therefore, ScandiDos AB's EBITDA margin for the quarter that ended in Apr. 2026 was 5.38%.
ScandiDos AB (OSTO:SDOS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
ScandiDos AB EBITDA Margin % Related Terms
ScandiDos AB EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for ScandiDos AB's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:SDOS vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, ScandiDos AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ScandiDos AB EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ScandiDos AB's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where ScandiDos AB's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ScandiDos AB (OSTO:SDOS) has a EBITDA Margin % of 5.38% as of Apr. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ScandiDos AB and its competitors. According to the industry distribution chart, ScandiDos AB ranks #505 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 61.9%.
Is ScandiDos AB's EBITDA Margin % too high?
ScandiDos AB's current EBITDA Margin % is 5.38%. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. ScandiDos AB's value of 5.38% is 28% below this industry median. Based on the distribution chart, ScandiDos AB ranks #505 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, ScandiDos AB has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ScandiDos AB's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ScandiDos AB ranks #505 out of 816 companies for EBITDA Margin %. This places ScandiDos AB in the lower half of its industry. The industry median EBITDA Margin % is 7.48. ScandiDos AB's value of 5.38% is 28% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ScandiDos AB's current EBITDA Margin % of 5.38% is 28% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ScandiDos AB and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ScandiDos AB's current EBITDA Margin % is 5.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ScandiDos AB stock overvalued right now?
Based on GuruFocus' analysis, ScandiDos AB (OSTO:SDOS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr1.15, compared to a current price of kr0.84 — trading 27.4% below its estimated fair value. The current EBITDA Margin % is 5.38% and 28% below the Medical Devices & Instruments industry median of 7.48. ScandiDos AB's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For ScandiDos AB (OSTO:SDOS), the current EBITDA Margin % is 5.38% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ScandiDos AB (OSTO:SDOS) Overvalued in 2026?
Based on GuruFocus' analysis, ScandiDos AB stock appears to be undervalued.
The current stock price of kr0.84 is trading 27.4% below its estimated GF Value™ of kr1.15.
GuruFocus considers ScandiDos AB to be Modestly Undervalued.
Key valuation signals for OSTO:SDOS:
EBITDA Margin %: 5.38%
GF Value™: kr1.15 vs. price of kr0.84 (27.4% below fair value)
Industry Position: 28% below the Medical Devices & Instruments median (#505 of 816)
No single metric tells the full story. See the OSTO:SDOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ScandiDos AB is engaged in providing radiation therapy for cancer. Its product, Delta4 Phantom+, and its various hardware and software options are at the heart of everything ScandiDos does, from product development and production to marketing, sales, and customer support. With Delta4 HexaMotion ScandiDos has successfully developed a motion platform that recreates the movement of the tumor in six dimensions and independently simulates the patient's breathing movement.
47GF Score
Get the complete analysis for OSTO:SDOS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SDOS has been successfully added to your 
